Laurimed LLC

Abbott Medical Optics Inc, located in Milpitas, CA, is a dedicated veterinary practice that emphasizes exceptional pet care through a combination of advanced technology and compassionate service. As a private employee-owned clinic, they prioritize the well-being of pets and the comfort of their owners, striving to create a welcoming environment where trust and communication thrive. The skilled veterinarians and staff at Abbott Medical Optics Inc are committed to providing comprehensive wellness care and support for pets, ensuring that every visit is a positive experience. With a focus on client education and personalized treatment plans, they aim to enhance the health and happiness of furry family members, reinforcing their mission of saving pets and extending joyful moments with them. Generated from the website

Nanomix is a nanotechnology company that has launched a portfolio of devices based on its proprietary sensation-detection technology. The company s nanoelectronic devices use ultra sensitive carbon nanotube sensing elements combined with proprietary chemistries. Its devices can be deployed across a broad range of industrial and medical applications where the low power consumption, small-form factor and high- sensitivity attributes of nanodetection technology offer performance advantages and enable access to critical information. Nanomix industrial detection devices provide improved accuracy, power consumption and are easily integrated into wireless applications. Its breath analysis products provide critical diagnostic and monitoring information for health care providers and individuals who need access to information for real-time patient assessment. Nanomix also markets a bio detection solution based upon its proprietary Sensation Detection Platform that simplifies conventional processes for scientists, medical professionals and others who need routine access to diagnostic information. Nanomix maintains its headquarters in Emeryville, Calif.

Founded in 1984, Kensey Nash Corporation is a medical technology company that develops and manufactures absorbable biomaterials-based products with applications in the cardiology, orthopedics, spine, drug and biologics delivery, periodontal/dental, surgical and wound-care markets. Its flagship product, the Angio-Seal vascular closure device, is designed to seal and close femoral artery punctures made during diagnostic and therapeutic cardiovascular catheterizations. The company also markets its proprietary TriActiv embolic protection system, a device designed to prevent microparticulates from traveling downstream during the treatment of diseased coronary saphenous vein bypass grafts. This system utilizes active flushing and extraction to remove debris from the vessel after a treatment procedure. The company also develops various bone graft substitutes fabricated from collagen, synthetic polymers and composite biomaterials. Kensey Nash Corporation maintains its United States headquarters in Exton, Penn., and its European headquarters in Germany.